Manzo Pharmaceutical (OTCMKTS:MNZO) Breaks the Silence
Manzo Pharmaceutical (OTCMKTS:MNZO) announced yesterday that they have started testing their Lacto-Freedom lactose intolerance treatment on humans. This, apparently, is the last major step before commercialization which, the management team have said numerous times...